REGN1400

REGN1400 · Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN1400, covering 2015-04-06 to 2015-04-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of REGN1400 Alone and in Combination With Erlotinib or Cetuximab in Patients With Certain Types of Cancer [Phase 1]

See pricing